Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.08
-12.8%
$5.06
$3.42
$7.20
$229.34M1.821.56 million shs4.79 million shs
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$6.04
-1.0%
$5.85
$4.35
$12.38
$303.63M0.43211,073 shs296,962 shs
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$22.05
+7.5%
$23.80
$6.20
$29.27
$243.87M-0.173,312 shs81,392 shs
Exicure, Inc. stock logo
XCUR
Exicure
$7.47
-2.0%
$10.16
$1.44
$36.00
$47.21M3.71560,560 shs5,486 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%-30.26%-25.82%-10.72%-19.84%
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
0.00%-5.92%+2.55%-13.71%-16.11%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
0.00%-11.98%-7.04%-20.88%+2,204,999,900.00%
Exicure, Inc. stock logo
XCUR
Exicure
0.00%-14.73%-25.60%-44.95%+2,097.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.23 of 5 stars
0.02.00.00.01.00.80.6
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
1.5908 of 5 stars
3.61.00.00.00.03.30.0
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3.5719 of 5 stars
4.60.00.00.01.14.20.6
Exicure, Inc. stock logo
XCUR
Exicure
1.5665 of 5 stars
0.04.00.04.72.60.80.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
3.25
Buy$22.00264.24% Upside
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3.13
Buy$46.29109.91% Upside
Exicure, Inc. stock logo
XCUR
Exicure
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest XCUR, AURA, PVLA, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$22.00
5/23/2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$19.00
5/16/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$53.00 ➝ $52.00
4/30/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
4/9/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$50.00
4/1/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
3/26/2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$19.00
3/26/2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
3/26/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00
3/25/2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$25.00
3/25/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$246.72M0.93$0.61 per share6.67$7.78 per share0.52
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
N/AN/AN/AN/A$3.04 per shareN/A
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$42.81M5.70N/AN/A$5.58 per share3.95
Exicure, Inc. stock logo
XCUR
Exicure
$500K94.42N/AN/A$1.12 per share6.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M$0.1137.099.27N/A1.32%0.13%0.10%8/6/2025 (Estimated)
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
-$86.92M-$1.90N/AN/AN/AN/A-58.63%-49.74%8/14/2025 (Estimated)
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
-$17.43M-$12.10N/AN/AN/AN/A-60.29%-43.30%8/13/2025 (Estimated)
Exicure, Inc. stock logo
XCUR
Exicure
-$9.70M-$4.81N/AN/AN/A-319.72%-82.41%8/11/2025 (Estimated)

Latest XCUR, AURA, PVLA, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
5/15/2025Q1 2025
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
-$0.47-$0.55-$0.08-$0.55N/AN/A
5/15/2025Q1 2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
-$3.40-$0.74+$2.66-$0.74N/AN/A
3/24/2025Q4 2024
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
-$0.43-$0.52-$0.09-$0.52N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
N/AN/AN/AN/AN/A
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/AN/AN/AN/AN/A
Exicure, Inc. stock logo
XCUR
Exicure
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
N/A
11.06
11.06
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/A
8.84
8.84
Exicure, Inc. stock logo
XCUR
Exicure
N/A
4.45
4.45

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
96.75%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
40.11%
Exicure, Inc. stock logo
XCUR
Exicure
42.82%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
5.40%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
20.50%
Exicure, Inc. stock logo
XCUR
Exicure
8.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,07356.21 million56.21 millionOptionable
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
5050.27 million47.55 millionNot Optionable
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/A11.06 million8.79 millionN/A
Exicure, Inc. stock logo
XCUR
Exicure
506.32 million5.79 millionNot Optionable

Recent News About These Companies

Exicure announces issuance of new patent in Australia
Kuehn Law Encourages Investors of Exicure, Inc. to Contact Law Firm
Exicure announces purchase agreement with GPCR Therapeutics
When the Price of (XCUR) Talks, People Listen
When (XCUR) Moves Investors should Listen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.08 -0.60 (-12.82%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.10 +0.01 (+0.37%)
As of 06/20/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aura Biosciences stock logo

Aura Biosciences NASDAQ:AURA

$6.04 -0.06 (-0.98%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$6.02 -0.01 (-0.25%)
As of 06/20/2025 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Palvella Therapeutics stock logo

Palvella Therapeutics NASDAQ:PVLA

$22.05 +1.54 (+7.51%)
As of 06/20/2025 04:00 PM Eastern

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Exicure stock logo

Exicure NASDAQ:XCUR

$7.47 -0.15 (-1.97%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$8.27 +0.80 (+10.72%)
As of 06/20/2025 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.